PreprintAll rights reservedbioRxiv
Clonogenic survival and relative biological effectiveness of pancreatic ductal adenocarcinoma under pristine and spread-out Bragg peak irradiation with protons and carbon ions.
- 1Mayo Clinic
Related
- Long-Term Outcomes of Anatomical and Biological Borderline Resectable Pancreatic Ductal Adenocarcinoma After Gemcitabine/S-1-Based Neoadjuvant Chemoradiotherapy
- Cost-Effectiveness of Daraxonrasib vs Chemotherapy in Previously Treated Metastatic Pancreatic Adenocarcinoma
- Borderline resectable pancreatic ductal adenocarcinoma: a narrative review
- Combined halp and GRIm scores for risk stratification in metastatic pancreatic ductal adenocarcinoma
- Exceptionally Durable Response to First-Line S-1 Monotherapy in Metastatic Pancreatic Adenocarcinoma: A Case Report
BibTeX
@misc{denbeigh2026clonogenic,
title = {{Clonogenic survival and relative biological effectiveness of pancreatic ductal adenocarcinoma under pristine and spread-out Bragg peak irradiation with protons and carbon ions.}},
author = {J. M. Denbeigh and A. Kneringer and W. E. Radstake and A. Parisi and S. Barna and S. Hartzell and S. Kerschbaum-Gruber and A. B. Dias and P. Fischer and H. Fuchs and D. M. Slade and D. Georg and C. J. Beltran},
howpublished = {bioRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.30.754978},
url = {https://www.biorxiv.org/content/10.64898/2026.09.30.754978v1},
}
RIS
TY - UNPB
TI - Clonogenic survival and relative biological effectiveness of pancreatic ductal adenocarcinoma under pristine and spread-out Bragg peak irradiation with protons and carbon ions.
AU - J. M. Denbeigh
AU - A. Kneringer
AU - W. E. Radstake
AU - A. Parisi
AU - S. Barna
AU - S. Hartzell
AU - S. Kerschbaum-Gruber
AU - A. B. Dias
AU - P. Fischer
AU - H. Fuchs
AU - D. M. Slade
AU - D. Georg
AU - C. J. Beltran
PY - 2026
DA - 2026/09/30
PB - bioRxiv
DO - 10.64898/2026.09.30.754978
UR - https://www.biorxiv.org/content/10.64898/2026.09.30.754978v1
ER -